Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - spj.science.org
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

[HTML][HTML] Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - ncbi.nlm.nih.gov
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

[HTML][HTML] Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan, S Wang… - Biomaterials …, 2022 - Springer
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

[HTML][HTML] Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and …

H Wu, G Wei, L Luo, L Li, Y Gao… - Biomaterials …, 2022 - biomaterialsres.biomedcentral.com
Combination of chemotherapy and immune checkpoint inhibitor therapy has greatly
improved the anticancer effect on multiple malignancies. However, the efficiency on triple …

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - search.proquest.com
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - search.ebscohost.com
Background: Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

H Wu, G Wei, L Luo, L Li, Y Gao, X Tan… - Biomaterials …, 2022 - europepmc.org
Background Combination of chemotherapy and immune checkpoint inhibitor therapy has
greatly improved the anticancer effect on multiple malignancies. However, the efficiency on …

Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and anti …

W Hao, W Guoli, L Lixia, L Lingchang, G Yibo… - 생체재료학회지, 2023 - dbpia.co.kr
Combination of chemotherapy and immune checkpoint inhibitor therapy has greatly
improved the anticancer effect on multiple malignancies. However, the efficiency on triple …

[引用][C] Ginsenoside Rg3 nanoparticles with permeation enhancing based chitosan derivatives were encapsulated with doxorubicin by thermosensitive hydrogel and …

H Wu, G Wei, L Luo, L Li, Y Gao… - Biomaterials …, 2022 - biomaterialsres.biomedcentral.com
Combination of chemotherapy and immune checkpoint inhibitor therapy has greatly
improved the anticancer effect on multiple malignancies. However, the efficiency on triple …